Treatment Strategies - Type 1 Diabetes
References 1. Shaw J E, Sicree R A, Zimmet P Z, “Global estimates of the prevalence of diabetes for 2010 and 2030“, Diabetes Res. Clin. Pract.(2010), 87:pp.4-14. 2. American Diabetes Association, “Standards of Medical Care in Diabetes – 2013“, Diabetes Care (2013),36:pp. S11-S66. 3. The Diabetes Control and Complications (DCCT) Research Group, “Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial“, Kidney Int. (1995),47:pp.1703–1720. 4. UK Prospective Diabetes Study Group, “Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes“, B M J (1998),317:pp.703–713. 5. Middleton R J, Foley R N, Hegarty J, et al., “The unrecognized prevalence of chronic kidney disease in diabetes“, Nephrol. Dial. Transplant.(2006),21:pp.88-92. 6. Jerums G, Premaratne E, Panagiotopoulos S, et al., “New and old markers of progression of diabetic nephropathy“, Diabetes research and clinical practice (2008),82 (Suppl 1):ppS30–S37. 7. De Boer I H, Steffes M W, “Glomerular filtration rate and albuminuria: twin manifestations of nephropathy in diabetes“, Journal of the American Society of Nephrology : JASN (2007),18:pp.1036–37. 8. Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group, “KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease“, Kidney International Supplements (2013),3:pp.1–150. 9. Botev R, Mallié J-P, Wetzels J F M, et al., “The clinician and estimation of glomerular filtration rate by creatinine-based formulas: current limitations and quo vadis“, Clinical journal of the American Society of Nephrology : CJASN (2011),6:pp.937–950. 10. Perrone R D, Madias N E, Levey A S, “Serum creatinine as an index of renal function: new insights into old concepts“, Clin. Chem. (1992),38:pp.1933-53. 11. Myers G L, Miller W G, Coresh J, et al., “Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program“, Clinical Chemistry (2006),52:pp.5–18.
72
Treatment Strategies - Diabetes
12. Florkowski C M, Chew-Harris J S, “Methods of Estimating GFR - Different Equations Including CKD-EPI“, Clin.Biochem.Rev. (2011),32:pp.75–79. 13. Cockcroft D W, Gault M, “Prediction of creatinine clearance from serum creatinine“, Nephron (1976), 16:pp. 31–41. 14. Stevens L A, Coresh J, Greene T, et al., “Assessing kidney function—measured and estimated glomerular filtration rate“, N. Engl. J. Med. (2006),354:pp-2473-83. 15. Levey A S, Bosch J P, Lewis J B, et al., “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group“, Ann. Intern. Med. (1999),130:pp.461-70. 16. Stevens L A, Stoycheff N, “Standardization of serum creatinine and estimated GFR in the Kidney Early Evaluation Program (KEEP)“. Am. J. Kidney Dis. (2008),51(S2):pp.S77-S82. 17. K/DOQI, “Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification“, Am. J. Kidney Dis. (2002),39(Suppl 1):pp. S1-S266. 18. Levey A S, Stevens L A, Schmid C H, et al. “A new equation to estimate glomerular filtration rate“, Ann. Intern. Med. (2009),150:pp.604-612. 19. Stevens L A, Schmid C H, Greene T, et al., “Comparative Performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study Equations for Estimating GFR Levels Above 60 mL/min/1.73 m2“, Am. J. Kidney Dis. (2010),56:pp.486–495. 20. Michels W M, Grootendorst D C, Verduijn M, et al., “Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size“, Clinical Journal of the American Society of Nephrology : CJASN (2010),5:pp.1003–9. 21. Vučić Lovrenčić M, Radišić Biljak V, Božičević S, et al., “Estimating glomerular filtration rate ( GFR ) in diabetes : The performance of MDRD and CKD-EPI equations in patients with various degrees of albuminuria“, Clinical Biochemistry (2012),45:pp. 1694–1696. 22. Delanaye P, Cavalier E, Mariat C, et al., “MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant?“ B M C
Nephrology 2010: 11/8 http://www.biomedcentral. com/1471-2369/11/8 23. Peralta C A, Shlipak M G, Judd S, et al., “Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality“, J A M A (2011),305:pp.1545–1552. 24. Inker L A, Schmid C H, Tighiouart H, et al., “Estimating glomerular filtration rate from serum creatinine and cystatin C“, N. Engl. J. Med.(2012),367:pp.20–29. 25. liadis F, Didangelos T, Ntemka A, et al., (2011) “Glomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations?“ Diabetologia (2011),54:pp.2987–2994. 26. Jerums G, Premaratne E, Panagiotopoulos S, et al., “The clinical significance of hyperfiltration in diabetes“, Diabetologia (2010),53:pp.2093–2104. 27. Premaratne E, MacIsaacs R J, Tsalamadris C et al., “Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate“, Diabetologia (2005),48:pp.2486-2493 28. Rigalleau V, Lasseur C, Perlemoine C, et al., “Estimation of glomerular filtration rate in diabetic patients, Cockcroft or MDRD formula?“, Diabetes Care (2005),28:pp.838–843 29. Rigalleau V, Beauvieux M, Gonzalez C, et al., „Estimation of renal function in patients with diabetes“, Diabetes and Metabolism (2011),37:p.359–366. 30. Rossing P, Rossing K, Gaede P, et al., “Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic Nephropathy“, Diabetes Care (206),29:pp.1024–1030. 31. Beauvieux M-C, Le Moigne F, Lasseur C, et al., “Monitoring of Kidney Function in Patients With Diabetes“, Diabetes Care (2007),30:pp.1988–1994. 32. Rognant N, Lemoine S, Laville M, et al., “Performance of the Chronic Kidney Disease Epidemiology Collaboration Equation to Estimate Glomerular Filtration Rate in Diabetic Patients“, Diabetes Care (2011),34:pp.1320-1322. 33. Silveiro S P, Araujo G N, Ferreira M N, et al., “Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) Equation Pronouncedly Underestimates Glomerular Filtration Rate in Type 2 Diabetes“, Diabetes Care (2011),34:pp.2353-2355.